Jardiance
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.jardiance.comRevenue
$5.2 MillionIndustry
About Jardiance
Is Jardiance your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Jardiance, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Jardiance has recently received funding, and reach out quickly before it becomes old news!
Check out if Jardiance is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Jardiance recently announced quarterly report
Product Launch: Get notified when Jardiance launches new products
Congratulate Masked Content for being promoted to Masked Content at Jardiance
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Jardiance had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Jardiance has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Jardiance
Compare insights from companies similar to Jardiance, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Jardiance
Company Profile Activity
Activity Insights
Jardiance is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Jardiance is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Jardiance.
Jardiance Tech Stack
A closer look at the technologies used by Jardiance
Jardiance News & Media
US FDA approves Jardiance® (empagliflozin) to treat adults living with heart failure with reduced ejection fraction
RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 18, 2021 /PRNewswire/ -- Jardiance® (empagliflozin) 10 mg has been approved by the U.S. Food and Drug Administration to reduce the risk of cardiovascular death plus hospitalization for heart failure in adults with heart failure with reduced...US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction
RIDGEFIELD, Conn. and INDIANAPOLIS, Jan. 11, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Jardiance® (empagliflozin) which is being investigated as a potential new treatment to reduce the risk of...Jardiance® associated with a total cost of care savings of more...
Highmark and Boehringer Ingelheim announced positive results from their outcomes-based agreement, which showed that adults with type 2 diabetes and known cardiovascular disease who took... (PRWeb December 15, 2020) Read the full story at https://www.prweb.com/releases/jardiance_associated_with_a_total_cost_of_care_savings_of_more_than_20_according_to_results_from_an_outcomes_based_agreement_between_boehringer_ingelheim_and_highmark/prweb17613452.htmJardiance® reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME® trial
RIDGEFIELD, Conn. and INDIANAPOLIS, Nov. 18, 2020 /PRNewswire/ -- Jardiance® (empagliflozin) reduced the risk of total (first plus recurrent) cardiovascular events compared with placebo, when both were given on top of standard of care, in adults with type 2 diabetes and established...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Jardiance
JARDIANCE is a prescription medicine used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. JARDIANCE is also used to reduce the risk of cardiovascular death in adults with type 2 diabetes who have known cardiovascular disease. JARDIANCE is not for people with type 1 diabetes or for people with diabetic ketoacidosis... Read More